Symbolbild · KI-generiert
MeiraGTx Holdings plc
Stock factsheet
Company data from public sources (TMX Money, Canadian Securities Exchange, Nasdaq screener, Wikidata); every ISIN is verified against its check digit. Where „—“ appears, no verified value exists — we do not publish unverified identifiers. Market capitalisation is an order of magnitude as of the date shown, not a real-time figure. The size class follows the thresholds in common use (micro < $300m, small < $2bn, mid < $10bn) and is meant as an indication, not a definition.
Company profile
MeiraGTx Holdings plc is a clinical-stage gene therapy company focused on diseases of the eye, nervous system and salivary glands. The company develops AAV-based gene therapies, including candidates for inherited retinal dystrophies and xerostomia. MeiraGTx operates its own manufacturing capabilities for gene therapy vectors.
Short profile generated automatically and checked for plausibility. A full editorial profile follows once we cover the company.
Share price
Price data from TradingView, possibly delayed. Not investment advice.
Comparable companies
Companies in the Biotech & Pharma sector of a similar size.
| Company | Ticker | Exchange | Market cap |
|---|---|---|---|
| MeiraGTx Holdings plc | MGTX | NASDAQ | 1,09 Mrd. USD |
| Seaport Therapeutics, Inc. | SPTX | NASDAQ | 1,10 Mrd. USD |
| Bioventus Inc. | BVS | NASDAQ | 1,10 Mrd. USD |
| Corvus Pharmaceuticals, Inc. | CRVS | NASDAQ | 1,12 Mrd. USD |
| Savara Inc. | SVRA | NASDAQ | 1,12 Mrd. USD |
| Wave Life Sciences Ltd. | WVE | NASDAQ | 1,06 Mrd. USD |
| PROCEPT BioRobotics Corporation | PRCT | NASDAQ | 1,06 Mrd. USD |
Investor Relations
We link only to primary sources from the company itself and from the regulators. Fields we have not recorded stay empty until a reliable source is available.
Information and education only — not investment advice, not a recommendation and not a financial analysis within the meaning of §85 WpHG or Art. 20 MAR. Investments in small and micro caps are highly speculative; total loss is possible. All information without warranty.